Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it will host an analyst day on June 19, 2014 at 12:30 p.m. EDT to discuss its next RNAi-based clinical candidate which targets a rare liver disease. A live webcast of the presentation and archive will be available on the Company’s website at www.arrowheadresearch.com. To access an audio only live presentation, dial 844-825-4406 toll free from the U.S. or 315-625-3230 for international callers and enter Conference ID 54600551.
Help employers find you! Check out all the jobs and post your resume.
